|
    MCK U.S.: NYSE

    江湖电竞直播app

    MCK US
    After Hours
    Last Updated: Sep 9, 2022 5:32 p.m. EDT Delayed quote

    $ 365.99

    -0.22 -0.06%
    After Hours Volume: 80.73K
    Close Chg Chg %
    $366.21 -3.95 -1.07%
    Advanced Charting
    Volume: 995.5K 65 Day Avg: 1.03M
    96% vs Avg
    365.96 Day Range 371.01
    193.89 52 Week Range 375.23

    Your Watchlists

    Customize 江湖电竞最新版比赛(江湖电竞投注app网站)

    Have Watchlists? Log in to see them here or sign up to get started.

    Symbol
    Company
    Price
    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    No Saved Watchlists

    Create a list of the investments you want to track.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    MCK Overview

    Key Data

    • Open $370.86
    • Day Range 365.96 - 371.01
    • 52 Week Range 193.89 - 375.23
    • Market Cap $53.2B
    • Shares Outstanding 143.73M
    • Public Float 143.5M
    • Beta 0.81
    • Rev. per Employee $3.579M
    • P/E Ratio 38.97
    • EPS $9.40
    • Yield 0.59%
    • Dividend $0.54
    • Ex-Dividend Date Aug 31, 2022
    • Short Interest 2.69M 08/15/22
    • % of Float Shorted 1.87%
    • Average Volume 1.03M

    Performance

    5 Day
    • 0.66%
    1 Month
    • 0.28%
    3 Month
    • 16.87%
    YTD
    • 47.33%
    1 Year
    • 80.64%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 14 Full Ratings

    Recent News

    Read full story

    McKesson Corp. stock falls Friday, underperforms market

    Read full story

    McKesson Corp. stock rises Thursday, outperforms market

    McKesson stock price target raised to $423 from $383 at BofA Securities

    Read full story

    McKesson Corp. stock rises Wednesday, still underperforms market

    Read full story

    McKesson Corp. stock falls Tuesday, underperforms market

    McKesson 1Q Profit Jumps Vs Year Earlier as Expenses, Charges Fell

    Read full story

    Ford Motor, Hershey, and McKesson Just Raised Their Dividends

    McKesson raises quarterly dividend by 15% to 54 cents a share from 47 cents

    McKesson Corp. said Monday its board has raised its quarterly dividend by 15% to 54 cents a share from 47 cents previously. The new dividend is payable Oct. 3 to shareholders of record as of Sept. 1. Shares were not activ...

    McKesson raises quarterly dividend to 54 cents a share from 47

    Read full story

    Nasdaq books longest win streak since November as U.S. stocks end mixed after stronger-than-expected jobs report

    AmerisourceBergen, McKesson, Cardinal Health to Pay $308M to Oklahoma in Opioid Suit

    McKesson, HCA Healthcare to form JV to increase access to cancer research, clinical trials

    McKesson Corp. and HCA Healthcare Inc. announced Thursday an agreement to form a joint venture to advance cancer care and boost access to oncology research. As part of the agreement, McKesson's U.S. Oncology Research (US...

    McKesson, HCA Healthcare to form oncology JV

    Read full story

    5 Healthcare Stocks That Are Bucking the Bear Market

    McKesson upgraded to buy from hold at Deutsche Bank

    Read full story

    Warren Buffett’s Berkshire Hathaway reveals new stakes in Paramount, Citigroup

    McKesson stock price target raised to $343 from $270 at Deutsche Bank

    McKesson stock price target raised to $331 from $280 at Mizuho

    McKesson stock price target raised to $331 from $280 at Mizuho

    Read full story

    As Time Passes, and the Weather Warms, Putin’s Power Play in Europe Loses Force

    Trump Ally Dr. Oz Hyped Unapproved 'Covid Cures' From Companies He Owns Shares Of

    on Benzinga.com

    3 Stocks to Buy If They Take a Dip

    on Motley Fool

    4 Growth Stocks to Buy and Hold No Matter What

    on StockNews.com

    Buffett Bought More of These 4 Stocks... Should You Follow His Lead?

    on StockNews.com

    5 “Strong Buy” Stocks to Buy This Week

    on StockNews.com

    This Stock Is Warren Buffett's Best 2022 Buy

    on Motley Fool

    2 Undervalued Stocks With Solid Growth Potential

    on StockNews.com

    Where McKesson Stands With Analysts

    on Benzinga.com

    Morgan Stanley Maintains Overweight Rating for McKesson: Here's What You Need To Know

    on Benzinga.com

    Netflix Price Target Cut By This Analyst, Plus Morgan Stanley Predicts $403 For McKesson

    on Benzinga.com

    Is It Too Late to Get in on This Warren Buffett Stock?

    on StockNews.com

    These Are the 16 Stocks Warren Buffett Has Bought in 2022

    on Motley Fool

    PYPL Up 51% Since July. Time To Buy?

    on Benzinga.com

    9 Stocks Warren Buffett Just Bought in the Second Quarter

    on Motley Fool

    3 Stock Winners and Losers of Biden’s Inflation Reduction Act

    on InvestorPlace.com

    This Indestructible Buffett Stock Is Soaring, But Is It a Buy?

    on Motley Fool

    Apple Up 25% Since June: Is It Time to Buy?

    on Benzinga.com

    This Lesser-Known Stock Has Moved 35% Since My Last Update, Here's What I'm Waiting For Next

    on Benzinga.com

    Credit Suisse Lifts Price Targets For Drug Distributors After Solid Q2 Performance

    on Benzinga.com

    3 Warren Buffett Stocks to Buy That Have Soared 31% to 104% This Year

    on Motley Fool

    McKesson Corp.

    McKesson Corp. engages in the provision of supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. It operates through the following segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products, provides practice management, technology, clinical support, and business solutions to community-based oncology, and other specialty practices, and sells financial, operational, and clinical solutions to pharmacies and provides consulting, outsourcing, technological, and other services. The International segment provides distribution and services to wholesale, institutional, and retail customers in European countries and Canada. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The RxTS segment brings together CoverMyMeds, RelayHealth, RxCrossroads, and McKesson Prescription Automation, including Multi-Client Central Fill as a Service, to serve biopharma and life sciences partners and patients. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX.

    Competitors

    Name Chg % Market Cap
    Amazon.com Inc. 2.56% $1.32T
    UnitedHealth Group Inc. -0.02% $493.42B
    CVS Health Corp. 0.05% $134.25B
    Elevance Health Inc. 1.23% $117.44B
    Cigna Corp. 0.78% $88.7B
    Walgreens Boots Alliance Inc. 1.17% $31.08B
    AmerisourceBergen Corp. -0.12% $30.58B
    Cardinal Health Inc. -0.69% $19.25B
    Hims & Hers Health Inc. 1.21% $1.37B
    Rite Aid Corp. 5.02% $404.41M